临床试验设备和辅助解决方案市场 - 按类型、服务、最终用户 - 全球预测

Clinical Trial Equipment & Ancillary Solutions Market - By Type, Service, End-user - Global Forecast

出版日期: 2024年04月29日 | 出版商:

Global Market Insights Inc. | 英文 160 Pages | 商品交期: 2-3个工作天内

价格

简介目录

在加强合作伙伴关係以推动创新和扩大先进技术的取得的推动下，临床试验设备和辅助解决方案市场预计从 2024 年到 2032 年将实现 7.5% 的复合年增长率。各公司正在联手整合不同的专业知识和资源，以加强远端监控设备和专用诊断工具等试验设备的开发和部署。这些合作也利用研究和技术的综合优势提高了试验效率和患者结果。例如，2024年5月，医疗保健研究和技术公司Clario宣布与临床试验医疗设备的着名供应商Emsere建立策略合作伙伴关係，透过结合专业知识和资源来增强临床试验设备和辅助解决方案。

整个市场分为类型、服务、最终用户和地区。

就类型而言，由于自动化样品处理和高通量分析系统等创新不断增加，实验室仪器领域的临床试验设备和辅助解决方案市场预计在2024 年至2032 年期间将出现显着的复合年增长率。这些仪器能够更有效地收集和分析资料，从而提高临床试验的精度和可靠性。该公司还整合尖端技术，例如用于即时资料分析和预测建模的人工智慧，以优化实验室工作流程并改善研究成果。

从最终用户来看，生物技术公司领域的临床试验设备和辅助解决方案产业预计将在 2024 年至 2032 年期间成长，这主要得益于基因治疗工具和先进诊断平台等尖端技术的广泛采用。这些公司正在增强其研究能力，以开发个人化治疗和标靶疗法，以改善患者的治疗结果和医疗保健功效。与学术机构和医疗保健提供者的合作也正在推动生物技术的进步，以促进更精确的临床试验，同时加速新型医疗解决方案的发展。

从地区来看，在慢性病增多和医疗保健进步的推动下，亚太地区临床试验设备和辅助解决方案市场规模预计将在 2024 年至 2032 年间呈现强劲成长。远端监控设备和数位健康平台等技术越来越多地被采用来提高患者护理和研究效率。这些进步正在增强进行复杂临床试验和收集即时健康资料的能力，以促进该地区更好的疾病管理和治疗结果。

产业生态系统分析
产业影响力
- 成长动力
  - 临床试验的全球化
  - 将临床试验外包给 CRO 的需求不断增长
  - 政府和非政府对临床试验的资助增加
  - 专注于以病人为中心的试验
  - 科技不断进步
- 产业陷阱与挑战
  - 复杂而严格的监管要求
  - 发展中国家基础建设有限
成长潜力分析
监管环境
按地区分類的临床试验量
波特的分析
PESTEL分析

第 4 章：竞争格局

介绍
公司矩阵分析
主要市场参与者的竞争分析
竞争定位矩阵
战略仪表板

第 5 章：市场估计与预测：按类型，2021 - 2032

主要趋势
诊断设备
实验室仪器
配对解决方案

第 6 章：市场估计与预测：按服务分类，2021 - 2032 年

主要趋势
租赁及租赁服务
供应及物流服务
监理合规服务
软体服务

第 7 章：市场估计与预测：按最终用户划分，2021 - 2032 年

主要趋势
製药和生物技术公司
合约研究组织 (CRO)
医疗器材企业
其他最终用户

第 8 章：市场估计与预测：按地区，2021 - 2032

主要趋势
北美洲
- 我们
- 加拿大
欧洲
- 德国
- 英国
- 法国
- 西班牙
- 义大利
- 荷兰人
- 欧洲其他地区
亚太地区
- 日本
- 中国
- 印度
- 澳洲
- 韩国
- 亚太地区其他地区
拉丁美洲
- 巴西
- 墨西哥
- 拉丁美洲其他地区
中东和非洲
- 沙乌地阿拉伯
- 南非
- 阿联酋
- 中东和非洲其他地区

第 9 章：公司简介

Andwin Scientific
Ancillare, LP.
AXELERIST FINANCIAL
Biocair
ICON plc
Imperial CRS, LLC.
Marken
MESM UK.
Myonex
NUVISAN
Oximio
Parexel International (MA) Corporation
Quipment SAS
Thermo Fisher Scientific Inc.

简介目录

Product Code: 9268

Clinical Trial Equipment and Ancillary Solutions Market is projected to accrue 7.5% CAGR from 2024 to 2032, driven by increasing partnerships for driving innovations and expanding access to advanced technologies. Companies are joining forces to integrate diverse expertise and resources for enhancing the development and deployment of trial equipment, such as remote monitoring devices and specialized diagnostic tools. These collaborations are also improving trial efficiency and patient outcomes for leveraging combined strengths in research and technology. For instance, in May 2024, Clario, a healthcare research and technology company, announced a strategic partnership with Emsere, a prominent supplier of medical equipment for clinical trials, to enhance clinical trial equipment and ancillary solutions through combined expertise and resources.

The overall market is segregated into type, service, end-user, and region.

In terms of type, the clinical trial equipment and ancillary solutions market from the laboratory instruments segment is expected to witness significant CAGR from 2024 to 2032 due to the increasing innovations, such as automated sample processing and high-throughput analysis systems. These instruments are enabling more efficient data collection and analysis for enhancing the precision and reliability of clinical trials. Companies are also integrating cutting-edge technologies, such as AI for real-time data analysis and predictive modeling to optimize laboratory workflows and improve research outcomes.

By End-User, the clinical trial equipment and ancillary solutions industry from the biotechnology companies segment is projected to rise from 2024 to 2032 led by higher adoption of cutting-edge technologies, such as gene therapy tools and advanced diagnostic platforms. These companies are enhancing their research capabilities to develop personalized treatments and targeted therapies to improve patient outcomes and healthcare efficacy. Collaborations with academic institutions and healthcare providers are also driving advancements in biotechnology for facilitating more precise clinical trials while accelerating the development of novel medical solutions.

Regionally, the Asia Pacific clinical trial equipment and ancillary solutions market size is projected to exhibit robust growth between 2024 and 2032, fueled by the rising chronic diseases and advancements in healthcare. Technologies, such as remote monitoring devices and digital health platforms are increasingly adopted to improve patient care and research efficacy. These advancements are enhancing the capability to conduct complex clinical trials and gathering real-time health data for facilitating better disease management and treatment outcomes in the region.

Chapter 1 Methodology & Scope

1.1 Market scope & definitions
1.2 Research design
- 1.2.1 Research approach
- 1.2.2 Data collection methods
1.3 Base estimates & calculations
- 1.3.1 Base year calculation
- 1.3.2 Key trends for market estimation
1.4 Forecast model
1.5 Primary research and validation
- 1.5.1 Primary sources
- 1.5.2 Data mining sources

Chapter 2 Executive Summary

2.1 Industry 360° synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Globalization of clinical trials
  - 3.2.1.2 Growing demand for outsourcing clinical trials to CROs
  - 3.2.1.3 Rise in government and non-government funding for clinical trials
  - 3.2.1.4 Focus on patient-centric trials
  - 3.2.1.5 Growing technology advancements
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 Complex and stringent regulatory requirements
  - 3.2.2.2 Limited infrastructure in developing countries
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Clinical trial volume, by region
3.6 Porter's analysis
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company matrix analysis
4.3 Competitive analysis of major market players
4.4 Competitive positioning matrix
4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Type, 2021 - 2032 ($ Mn)

5.1 Key trends
5.2 Diagnostic equipment
5.3 Laboratory instruments
5.4 Ancillary solutions

Chapter 6 Market Estimates and Forecast, By Service, 2021 - 2032 ($ Mn)

6.1 Key trends
6.2 Rental & leasing services
6.3 Supply and logistics services
6.4 Regulatory compliance services
6.5 Software services

Chapter 7 Market Estimates and Forecast, By End-User, 2021 - 2032 ($ Mn)

7.1 Key trends
7.2 Pharmaceutical & biotechnology companies
7.3 Contract research organizations (CROs)
7.4 Medical device companies
7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Spain
- 8.3.5 Italy
- 8.3.6 The Netherlands
- 8.3.7 Rest of Europe
8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 Saudi Arabia
- 8.6.2 South Africa
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa